<SEC-DOCUMENT>0001640334-19-000350-index.html : 20190304
<SEC-HEADER>0001640334-19-000350.hdr.sgml : 20190304
<ACCEPTANCE-DATETIME>20190304172527
ACCESSION NUMBER:		0001640334-19-000350
CONFORMED SUBMISSION TYPE:	SC 13G
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20190304
DATE AS OF CHANGE:		20190304

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Inmune Bio, Inc.
		CENTRAL INDEX KEY:			0001711754
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				475205835
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-90859
		FILM NUMBER:		19655211

	BUSINESS ADDRESS:	
		STREET 1:		1224 PROSPECT STREET
		STREET 2:		SUITE 150
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037
		BUSINESS PHONE:		8589643720

	MAIL ADDRESS:	
		STREET 1:		1224 PROSPECT STREET
		STREET 2:		SUITE 150
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Toucan Capital Fund III, L.P.
		CENTRAL INDEX KEY:			0001626842
		IRS NUMBER:				451742900
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G

	BUSINESS ADDRESS:	
		STREET 1:		4800 MONTGOMERY LANE, SUITE 800
		CITY:			BETHESDA
		STATE:			MD
		ZIP:			20814
		BUSINESS PHONE:		240-497-4060

	MAIL ADDRESS:	
		STREET 1:		4800 MONTGOMERY LANE, SUITE 800
		CITY:			BETHESDA
		STATE:			MD
		ZIP:			20814
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G
<SEQUENCE>1
<FILENAME>toucan_sc13g.htm
<DESCRIPTION>SC 13G
<TEXT>
Document 1 - file: toucan_sc13g.htm

</DOCUMENT>
</SEC-DOCUMENT>